Cargando…

Cellular localization of kinin B(1 )receptor in the spinal cord of streptozotocin-diabetic rats with a fluorescent [N(α)-Bodipy]-des-Arg(9)-bradykinin

BACKGROUND: The kinin B(1 )receptor (B(1)R) is upregulated by pro-inflammatory cytokines, bacterial endotoxins and hyperglycaemia-induced oxidative stress. In animal models of diabetes, it contributes to pain polyneuropathy. This study aims at defining the cellular localization of B(1)R in thoracic...

Descripción completa

Detalles Bibliográficos
Autores principales: Talbot, Sébastien, Théberge-Turmel, Patrick, Liazoghli, Dalinda, Sénécal, Jacques, Gaudreau, Pierrette, Couture, Réjean
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667487/
https://www.ncbi.nlm.nih.gov/pubmed/19323833
http://dx.doi.org/10.1186/1742-2094-6-11
Descripción
Sumario:BACKGROUND: The kinin B(1 )receptor (B(1)R) is upregulated by pro-inflammatory cytokines, bacterial endotoxins and hyperglycaemia-induced oxidative stress. In animal models of diabetes, it contributes to pain polyneuropathy. This study aims at defining the cellular localization of B(1)R in thoracic spinal cord of type 1 diabetic rats by confocal microscopy with the use of a fluorescent agonist, [Nα-Bodipy]-des-Arg(9)-BK (BdABK) and selective antibodies. METHODS: Diabetes was induced by streptozotocin (STZ; 65 mg/kg, i.p.). Four days post-STZ treatment, B(1)R expression was confirmed by quantitative real-time PCR and autoradiography. The B(1)R selectivity of BdABK was determined by assessing its ability to displace B(1)R [(125)I]-HPP-desArg(10)-Hoe140 and B(2)R [(125)I]-HPP-Hoe 140 radioligands. The in vivo activity of BdABK was also evaluated on thermal hyperalgesia. RESULTS: B(1)R was increased by 18-fold (mRNA) and 2.7-fold (binding sites) in the thoracic spinal cord of STZ-treated rats when compared to control. BdABK failed to displace the B(2)R radioligand but displaced the B(1)R radioligand (IC(50 )= 5.3 nM). In comparison, IC(50 )values of B(1)R selective antagonist R-715 and B(1)R agonist des-Arg(9)-BK were 4.3 nM and 19 nM, respectively. Intraperitoneal BdABK and des-Arg(9)-BK elicited dose-dependent thermal hyperalgesia in STZ-treated rats but not in control rats. The B(1)R fluorescent agonist was co-localized with immunomarkers of microglia, astrocytes and sensory C fibers in the spinal cord of STZ-treated rats. CONCLUSION: The induction and up-regulation of B(1)R in glial and sensory cells of the spinal cord in STZ-diabetic rats reinforce the idea that kinin B(1)R is an important target for drug development in pain processes.